Speakers - CRDWC 2025

Biography

Tiziana Parisi is the CEO, CSO and co-founder of Paralog Therapeutics Inc., a precision medicine company focused on the development of anti-cancer therapies. Dr. Parisi has longstanding interests in modeling and targeting signaling pathways that control tumorigenesis and disease. Throughout her career in academia, biotech, and their interface, Dr. Parisi has uncovered a variety of previously unappreciated gene functions in cancer, disease, immunity, development, stemness, and transcription. Prior to joining Paralog Therapeutics Inc., Dr. Parisi conducted research at the Massachusetts Institute of Technology. At MIT, Dr. Parisi generated and studied a multitude of mouse models of cancer and disease. Moreover, in the last six years, Dr. Parisi initiated a multidisciplinary collaboration between MIT and Johnson & Johnson, aimed at detecting and intercepting lung cancer at its early stages. Dr. Parisi performed part of her postdoctoral studies at the DNAX Research Institute (Schering Plough, Palo Alto, CA), where she focused on genes that control stemness, cell proliferation, and cancer. Dr. Parisi holds a Ph.D. from the University of Naples Federico II in Italy, where she studied the function and regulation of tumor suppressor genes and contributed to elucidating the structure and function of endogenous retroviruses in humans and primates. Dr. Parisi strives to enrich the scientific environment by serving as a reviewer, mentor and collaborator in diverse settings.